On Medical Mondays,

Dr. Brad Tolin, a primary investigator of the NeoCart® clinical trials from the San Antonio TX Orthopedic Group explains NeoCart®.
NeoCart® is a Phase 3 investigational product that utilizes many aspects of a regenerative medicine platform to repair knee cartilage damage using tissue implants made from a patient’s own cells.